🔎 Trials Near Me

Domov › Debelost › Texas › Houston

Klinične študije za Debelost v Houston, TX

43 študij za Debelost išče udeležence na lokacijah v Houston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Vključevanje udeležencevFaza 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 mi stran
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Vključevanje udeležencevFaza 2
  • Cardiovascular Specialists of Willowbrook, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Vključevanje udeležencevFaza 3
  • PlanIt Research, PLLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Vključevanje udeležencevFaza 3
  • DM Clinical, Houston
Starost 8–18 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Vključevanje udeležencevFaza 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Vključevanje udeležencevFaza 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Vključevanje udeležencevFaza 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • in še 1
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Juno Research, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Vključevanje udeležencevFaza 3
  • Juno Research, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Vključevanje udeležencevFaza 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • in še 2
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Vključevanje udeležencevFaza 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • PlanIt Research, PLLC, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
  • The University of Texas Health Science Center at Houston, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • AURORA-2 Clinical Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Vključevanje udeležencevFaza 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • in še 3
Starost 18–99 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Vključevanje udeležencevFaza 2
  • Juno Research, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Vključevanje udeležencevFaza 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Vključevanje udeležencevFaza 3
  • Houston Pulm Med Res Network, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07571109

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Vključevanje udeležencevFaza 2
  • PlanIt Research, PLLC, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Vključevanje udeležencevFaza 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Vključevanje udeležencevFaza 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Vključevanje udeležencevFaza 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi stran
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Vključevanje udeležencevFaza 3
  • Kailera Clinical Site, Bellaire · 7 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Vključevanje udeležencevFaza 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 mi stran
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Vključevanje udeležencevFaza 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Starost 18–99 · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Vključevanje udeležencevFaza 3
  • Research Site, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Vključevanje udeležencevFaza 2
  • Baylor Texas Children's Hospital, Houston
Starost 7–25 · Vsi spoli · Posodobljeno 19. avg. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Vključevanje udeležencevFaza 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Vključevanje udeležencevFaza 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents

Vključevanje udeležencevVabljeni zdravi prostovoljci
  • Children's Nutrition Research Center, Houston
Starost 12–18 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06959901

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Vključevanje udeležencevVabljeni zdravi prostovoljciOmenja plačilo za udeležence
  • USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston
Starost 14–16 · Vsi spoli · Posodobljeno 7. jul. 2026 · NCT06943001

Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Lilli Health, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. maj 2026 · NCT05950282

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Vključevanje udeležencev
  • M D Anderson Cancer Center, Houston
Starost 18 in več · Ženske · Posodobljeno 21. apr. 2026 · NCT04003038

Incretin Microdosing for Cardiometabolic Health in People With HIV

Vključevanje udeležencevFaza 2
  • The University of Texas Health Science Center at Houston, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 18. feb. 2026 · NCT07325500

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Vključevanje udeležencevFaza 2
  • Baylor College of Medicine, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 16. jan. 2026 · NCT06273072

RESET System Pivotal Trial (Rev F)

Vključevanje udeležencev
  • Baylor College of Medicine, Houston
Starost 22–65 · Vsi spoli · Posodobljeno 18. jul. 2024 · NCT04101669

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

Vključevanje udeležencev
  • Houston Methodist Hospital, Houston
Starost 18 in več · Vsi spoli · Posodobljeno 1. apr. 2024 · NCT06339320

Študije za Debelost v drugih mestih

Druge študije v Houston

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.